• No results found

Clinical proteomics in oncology : a passionate dance between science and clinic

N/A
N/A
Protected

Academic year: 2021

Share "Clinical proteomics in oncology : a passionate dance between science and clinic"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Clinical proteomics in oncology : a passionate dance between science

and clinic

Noo, M.E. de

Citation

Noo, M. E. de. (2007, October 9). Clinical proteomics in oncology : a passionate dance

between science and clinic. Retrieved from https://hdl.handle.net/1887/12371

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the

Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12371

Note: To cite this publication please use the final published version (if applicable).

(2)

Clinical Proteomics in

oncology:

A passionate dance between

science and clinic

(3)

Cover: L’etoile [La danseuse sur la scene] 1871, by Edgar Degas, Musee d’Orsay, Paris

© 2007, M.E. de Noo ISBN 978-90-9022-020-8

Printed by Optima Grafi sche Communicatie B.V. Rotterdam

This thesis is fi nancially supported by BIOMET, Farwick Groenspecialisten,Greiner, KCI Medical, LCS Systemen, Nycomed, Roche, Sanofi Aventis, Smith & Nephew Hoofddorp, Stichting ter bevordering van de Chirurgische Wetenschappen te Leiden, Tyco Healthcare

(4)

Clinical Proteomics in

oncology:

A passionate dance between

science and clinic

Proefschrift ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van de rector Magnifi cus prof. mr. P.F. van der Heijden, volgens besluit van het College voor Promoties

te verdedigen op dinsdag 9 oktober 2007 klokke 16.15 uur

door Mirre E. de Noo geboren te Enschede in 1978.

(5)

PROMOTIECOMMISSIE:

Promotores : Prof. Dr. A.M. Deelder Prof. Dr. R.A.E.M. Tollenaar

Referent: Dr. L. van ’t Veer (NKI-AVL, Amsterdam) Overige Leden: Prof. Dr. I.H.M. Borel Rinkes (UMC, Utrecht)

Prof. M.J. Duffy (St. Vincent’s University Hospital, Dublin) Dr. M. Frohlich

Prof. Dr. D.W. Hommes Dr. B.J.A. Mertens

Prof. Dr. C.J.H. van de Velde

(6)

Voor Han

(7)

Surgeons must be very careful When they take the knife Underneath their fi ne incisions Stirs the culprit–Life!

Emily Dickinson

(8)

CONTENTS

Chapter 1 Introduction 9

Chapter 2 Translational research in prognostic profi ling in colorectal cancer

Dig Surg 2005, 22:276-81

23

Chapter 3 Reliability of human serum protein profi les generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry Anal Chem 2005, 77 (22):7232-41

35

Chapter 4 The use of serological protein profi les for the detection of colorectal cancer

Eur J Canc 2006, 42 (8):1068-76

55

Chapter 5 Mass spectrometry proteomic diagnosis; enacting the double cross validatory paradigm

J Comp Biol 2006, 13(9):1591-605

73

Chapter 6 MALDI-TOF serum protein profi les for the detection of breast cancer

Onkologie 2006, 29(11):501-6

97

Chapter 7 Validation of serological protein profi les for the detection of breast cancer

Submitted

111

Chapter 8 General Discussion: Current status and prospects of clinical proteomics studies on the detection of colorectal cancer: hopes and fears

World J Gastroenterol 2006, 12(41):6594-601

127

Chapter 9 Nederlandse samenvatting

Tijdschrift kanker 2006, 30 (4): 20-26r

145

Dankwoord 153

Curriculum vitae 157

List of publications 159

(9)

Referenties

GERELATEERDE DOCUMENTEN

Although previous studies have reported similar high classifi cation results for various solid tumours, we prefer evaluation through a thorough study design and

We will discuss the essential aspects of the study design fi rst, followed by a de- scription of the discriminant method and the double cross-validatory approach to joint

We favour a thorough and stringent study design and double cross-validation of our classifi cation model.[19] We feel that the use of standardised serum collection and

stringent demands have been proposed on both study design and experimental pro- cedures for proteomic profi ling.[12-14] Subsequently, several groups have stressed the importance

Further refi nement of serum protein profi les is needed before these mass spec- trometry based techniques become part of clinical routine. Nowadays, several stud- ies have

Deze discriminerende eiwitprofi elen kunnen als diagnostische of prognostische test gebruikt worden, of zelfs targets vormen voor nieuwe behandelingsstrategieën.. De meeste

Bert Bonsing voor de arcade van Riolan en de motivatie, Gerrit-Jan Liefers voor het aanstekelijke enthousiasme voor de wetenschap, Henk Hartgrink voor het rolmodel van een top

These double cross validated results yielded a total recognition rate of 86%, a sensitivity of 84% and a specificity of 88% for the detection of breast cancer within the